中国药物警戒 ›› 2017, Vol. 14 ›› Issue (6): 364-368.

• 安全性评价与合理用药 • 上一篇    下一篇

1087例不同来源狂犬免疫球蛋白的不良反应文献分析

沈洁,顾海燕,张维   

  1. 南京市第二医院药剂科, 江苏 南京 210003
  • 收稿日期:2017-02-15 修回日期:2017-08-17 出版日期:2017-06-20 发布日期:2017-08-17
  • 作者简介:沈洁,女,硕士,主管药师,医院药学。

Literature Analysis of 1087 Cases of Adverse Reactions Induced by Different Rabies Immunoglobulin

SHEN Jie, GU Hai-yan, ZHANG Wei   

  1. Department of Pharmacy, Second Hospital of Nanjing, Jiangsu Nanjing 210003, China
  • Received:2017-02-15 Revised:2017-08-17 Online:2017-06-20 Published:2017-08-17

摘要: 目的 讨论接种不同来源狂犬免疫球蛋白后发生不良反应的特征,以期预防和及时处理该类不良反应。方法 以1956年至2016年为限,检索中国知网中关于狂犬免疫球蛋白不良反应病例的公开报道,并统计与分析。结果 检索到75篇符合标准的文献,共计1 087例;抗狂犬病血清与狂犬病人免疫球蛋白不良反应的发生均无明显的性别差异,抗狂犬病血清的不良反应以20岁以下的患者最多,其发生具有一定的潜伏期,可达一周以上;而狂犬病人免疫球蛋白的不良反应多发生于注射30 min内,其构成比达到85.06%;抗狂犬病血清的不良反应病例数较多,有986例,以血清病为主;而狂犬病人免疫球蛋白的不良反应病例数较少,仅有101例,多呈现晕厥及血管迷走神经反射(VVRS)等反应。结论 医护人员和患者家属应结合患者接种的狂犬免疫球蛋白种类,在接种前后及接种过程中都应密切观察患者的反应,接种前准备好抢救措施。

关键词: 抗狂犬病血清, 狂犬病人免疫球蛋白, 不良反应, 文献分析

Abstract: Objective To discuss the characteristics of adverse reactions(ARs) induced by different rabies immunoglobulin, in order to prevent and rescue these adverse reactions in time. Methods AR cases induced by rabies immunoglobulin reported in CNKI from 1956 to 2016 were retrieved and analyzed statistically. Results 75 standard literatures were retrieved, a total of 1087 cases. In these statistic cases, there were no significant differences in gender between anti-rabies serum and human rabies immunoglobulin, and most of the patients are under 20 years of age in anti-rabies serum. The adverse reactions of anti-rabies serum had a certain incubation period, up to a week. And the adverse reactions of human rabies immunoglobulin were more than 85.06% within 30 min after injection. There were 986 cases of anti-rabies serum, mainly serum disease. While human rabies immunoglobulin has lower incidence, only 101 cases showed more adverse reactions such as syncope and vasovagal reflections (VVRS). Conclusion The medical staff and the family members of the patients should be combined with the rabies immunoglobulin inoculated with the patients. The response of the patients should be closely observed before and after the inoculation, and rescue measures should be prepared before the vaccination.

Key words: anti-rabies serum, human rabies immunoglobulin, adverse reactions (ARs), literature analysis

中图分类号: